SBIR/STTR Research Award

Non-invasive efficient brain delivery of Prussian Blue for treatment of Alzheimer disease

Award identifier 3152fff04f0ddbbc239289447f59d7533d835e52e5e752074b5f384649c8d75aAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$1,459,774

Program and phase

SBIR · Phase II

Award year

2020

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
Weinberg Medical Holdings
Proposal award date
2020-09-01
Contract end date
2022-08-31
UEI
CACBXGF9BC17
Solicitation number
PAS18-187
Topic code
NIA

Research abstract

Abstract Direct brain injection of radical-scavenging dyes (e.g. Prussian blue) prevents and cures Alzheimer’s disease in animal models. In human tests of orally administered blue dyes, however, reaching therapeutic concentration levels in the brain has not been achievable. Our published rodent experiments have shown that helical magnetic fields can drill magnetic nanorods from the nose into the brain with very high efficiency. Rodent studies have shown no toxicity after 30-days of particle implantation. In the first phase of this fast- track project, we will validate that our magnetic drilling methods can deliver therapeutic levels of blue dye in the brain non-invasively. In the second phase we will verify that this delivery method improves cognition in a rodent model of Alzheimer disease (AD). Accomplishment of this goal will pave the way to human studies, aided by already- committed investors in the project and by experienced academic partners with whom we have worked for over a decade.Narrative Direct brain injection of radical-scavenging dyes (e.g. Prussian blue) prevents and cures Alzheimer’s disease in animal models. In human tests of orally administered blue dyes, however, reaching therapeutic concentration levels in the brain has not been achievable. Our published rodent experiments have shown that helical magnetic fields can drill magnetic nanorods from the nose into the brain with very high efficiency. In the first phase of this fast-track project, we will validate that our magnetic drilling methods can deliver therapeutic levels of blue dye in the brain non-invasively. In the second phase we will verify that this delivery method improves cognition in a rodent model of Alzheimer disease (AD). Accomplishment of this goal will pave the way to human studies, aided by already- committed investors in the project and by experienced academic partners with whom we have worked for over a decade.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

28 SBIR/STTR records share this UEI (2007–2022). Reported award amounts total $23,808,895. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services, Department of Defense, National Science Foundation, Department of Commerce, Department of Energy

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.